Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 833.00 INR
Change Today 0.00 / 0.00%
Volume 0.0
GNP On Other Exchanges
Symbol
Exchange
Natl India
OTC US
As of 6:05 AM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Cherylann Maria Pinto B.Pharm

Director of Corporate Affairs, Executive Director and Member of Shareholders/Investors Grievance Committee, Glenmark Pharmaceuticals Ltd.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 1 different industries.

See Board Relationships
4722,720,045
As of Fiscal Year 2014

Background*

Ms. Cherylann Maria Pinto, also known as Cheryl, B.Pharm serves as a Director of Corporate Affairs and has been an Executive Director at Glenmark Pharmaceuticals Ltd. since October 6, 1999. Mrs. Pinto has over 24 years experience in the pharmaceutical business. Mrs. Pinto is a graduate in Pharmacy from the University of Bombay.

Corporate Headquarters*

Glenmark House
Mumbai, Maharashtra 400099

India

Phone: 91 22 4018 9999
Fax: 91 22 4018 9990

Board Members Memberships*

1999-Present
Director of Corporate Affairs, Executive Director and Member of Shareholders/Investors Grievance Committee

Education*

Unknown/Other Education
University of Mumbai

Other Affiliations*

Annual Compensation*

Salary18,329,049
Total Annual Compensation18,329,049

Stock Options*

All Other Compensation4,390,996

Total Compensation*

Total Annual Cash Compensation22,720,045
Total Short Term Compensation18,329,049
Other Long Term Compensation4,390,996
Total Calculated Compensation22,720,045
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNP:IN 833.00 INR 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kalyanasundaram Subramanian Chief Executive Officer and Director
Taro Pharmaceutical Industries Ltd.
--
Pankaj R. Patel M.PharmChairman, Managing Director, Chairman of Share Transfer Committee, Chairman of Committee of Directors and Member of Shareholders'/Investors' Grievance Committee
Cadila Healthcare Limited
--
Arun Sawhney B.Com., P.G.D.B.M.Chief Executive Officer, Managing Director, Executive Director, Member of Shareholders/Investors Grievance & Share Transfer Committee, Member of Quality & Integrity Committee, Member of Science Committee and Member of Corporate Social Responsibility Committee
Ranbaxy Laboratories Ltd.
122.7M
Arthur P. Bedrosian J.D.Chief Executive Officer, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$539.0K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLENMARK PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.